ADINOLFI, Luigi Elio
 Distribuzione geografica
Continente #
EU - Europa 24.706
NA - Nord America 15.620
AS - Asia 9.676
SA - Sud America 1.611
Continente sconosciuto - Info sul continente non disponibili 625
AF - Africa 130
OC - Oceania 10
Totale 52.378
Nazione #
US - Stati Uniti d'America 15.296
RU - Federazione Russa 15.035
SG - Singapore 3.649
IE - Irlanda 2.685
CN - Cina 2.019
IT - Italia 1.809
HK - Hong Kong 1.555
UA - Ucraina 1.418
BR - Brasile 1.380
GB - Regno Unito 1.149
VN - Vietnam 1.044
DE - Germania 979
SE - Svezia 435
FI - Finlandia 394
TR - Turchia 357
KR - Corea 291
FR - Francia 281
IN - India 244
GR - Grecia 232
JP - Giappone 173
CA - Canada 160
AR - Argentina 82
MX - Messico 61
BD - Bangladesh 60
NL - Olanda 59
ID - Indonesia 46
EC - Ecuador 41
IQ - Iraq 39
ZA - Sudafrica 36
AT - Austria 35
BE - Belgio 35
PL - Polonia 33
CO - Colombia 29
MA - Marocco 27
RO - Romania 27
ES - Italia 25
EU - Europa 20
CZ - Repubblica Ceca 19
IR - Iran 19
CL - Cile 18
PY - Paraguay 18
UZ - Uzbekistan 18
EG - Egitto 17
HN - Honduras 17
PK - Pakistan 17
IL - Israele 15
SA - Arabia Saudita 15
VE - Venezuela 15
CR - Costa Rica 13
MY - Malesia 13
JM - Giamaica 12
UY - Uruguay 12
PE - Perù 10
PH - Filippine 10
TW - Taiwan 10
AE - Emirati Arabi Uniti 9
AU - Australia 9
NI - Nicaragua 9
NP - Nepal 9
TT - Trinidad e Tobago 9
DZ - Algeria 8
KE - Kenya 8
LT - Lituania 8
SC - Seychelles 8
BG - Bulgaria 7
GT - Guatemala 7
CW - ???statistics.table.value.countryCode.CW??? 6
ET - Etiopia 6
KZ - Kazakistan 6
LB - Libano 6
OM - Oman 6
PR - Porto Rico 6
TN - Tunisia 6
AL - Albania 5
AZ - Azerbaigian 5
BB - Barbados 5
BO - Bolivia 5
CH - Svizzera 5
GE - Georgia 5
PA - Panama 5
PS - Palestinian Territory 5
PT - Portogallo 5
SV - El Salvador 5
TH - Thailandia 5
DO - Repubblica Dominicana 4
HU - Ungheria 4
JO - Giordania 4
SN - Senegal 4
AM - Armenia 3
CY - Cipro 3
EE - Estonia 3
GP - Guadalupe 3
HR - Croazia 3
KG - Kirghizistan 3
NO - Norvegia 3
AO - Angola 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
DK - Danimarca 2
Totale 51.743
Città #
Moscow 5.246
Dublin 2.678
Jacksonville 2.129
Santa Clara 1.805
Hong Kong 1.531
San Jose 1.386
Singapore 1.369
Chandler 1.305
Ashburn 1.235
Council Bluffs 851
Princeton 455
Ho Chi Minh City 322
Roxbury 311
Bremen 297
Seoul 279
New York 272
Milan 267
Hanoi 261
Medford 253
Beijing 232
Ann Arbor 218
Boardman 215
Wilmington 195
Hefei 189
The Dalles 186
Woodbridge 186
Cambridge 182
Dallas 159
Bengaluru 128
San Mateo 124
Nanjing 108
Naples 107
Düsseldorf 102
São Paulo 102
Los Angeles 101
Munich 95
Caserta 94
Des Moines 87
Da Nang 78
Jinan 74
Miano 73
Mountain View 73
Napoli 65
Shenyang 57
Orem 54
Haiphong 49
Memphis 47
Norwalk 41
Frankfurt am Main 40
Nanchang 40
Helsinki 39
Tianjin 38
Atlanta 37
Toronto 37
Rio de Janeiro 36
Rome 35
Shanghai 35
Zhengzhou 35
Chicago 34
Guangzhou 34
Venice 34
Brussels 33
Amsterdam 32
Houston 32
North Bergen 32
Changsha 31
Washington 31
Nuremberg 30
Brasília 29
Belo Horizonte 27
Tokyo 27
Chennai 26
Hangzhou 26
Montreal 25
Turku 25
Brooklyn 24
Phoenix 24
Haikou 23
Warsaw 23
Campinas 21
Hải Dương 21
Kunming 20
Thái Nguyên 20
London 19
Ningbo 19
Auburn Hills 18
Bologna 18
Curitiba 18
Hebei 18
Florence 17
Palermo 17
Salvador 17
Taizhou 17
Marano Di Napoli 16
Porto Alegre 16
Baghdad 15
Falkenstein 15
Johannesburg 15
Lanzhou 15
Quito 15
Totale 27.014
Nome #
Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study 229
Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C 222
Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study 216
Cannabinoid receptor 2-63 QQ varianti s associated with severe necroinflammation in chronic epatiti C 216
Bioelectrical impedance analysisfor the assessment of body composition in patients with systemic sclerosis 216
Clinical efficacy of dirithromycin versus miocamycin in tonsillopharyngitis 209
Anti-envelope 1 and 2 immune response in chronic hepatitis C patients: Effects of hepatitis B virus co-infection and interferon treatment 205
A genic and epigenetic combination therapy for liver cancer 205
Association Between a Polymorphism in Cannabinoid Receptor 2 and Severe Necroinflammation in Patients With Chronic Hepatitis C. 200
Mechanisms and clinical behavior of hepatocellular carcinoma in HBV and HCV infection and alcoholic and non-alcoholic fatty liver disease 199
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 196
Cannabinoid receptor 2-63 QQ variant is associated with persistently normal aminotransferase serum levels in chronic hepatitis C 194
Ankle-Brachial Index and cardiovascular events in atrial fibrillation The ARAPACIS Study 194
Non-invasive respiratory support in SARS-CoV-2 related acute respiratory distress syndrome: when is it most appropriate to start treatment? 192
Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration 191
Cannabinoid Receptor 2 (CB2) Q63 variant in chronic hepatitis C: an association with a more severe hepatocellular necrosis. 187
Sviluppo di un questionario autocompilato per la valutazione delle opinioni dei familiari sulle cause e le conseguenze psicosociali della schizofrenia (QOF) 187
Activity of aminoglycosides against phagocytosed bacteria 186
CB2-63 polymorphism and immune-mediated diseases associated with HCV chronic infection. 184
Endocardite da Gemella morbillorum: descrizione di due casi 183
Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms 182
Acute rhabdomiolisys in healthy woman. 177
Predictors of in-hospital mortality of COVID-19 patients and the role of telemetry in an internal medicine ward during the third phase of the pandemic 175
Epidemiology of HCV and HBV in a High Endemic Area of Southern Italy: Opportunities from the COVID-19 Pandemic—Standardized National Screening or One Tailored to Local Epidemiology? 173
Metabolic dysfunction-associated steatotic liver disease (MASLD): a systemic disease with a variable natural history and challenging management 173
Antimicrobici e sistema immune dell'ospite: bioattività intrafagocitica di antibiotici beta-lattamici 173
IMPACT OF TYPE II DIABETES ON HCC APPEARANCE IN PATIENTS TREATED WITH DIRECT ACTING ANTIVIRALS 173
Cardiorenal Impact of SGLT-2 Inhibitors: A Conceptual Revolution in The Management of Type 2 Diabetes, Heart Failure and Chronic Kidney Disease 173
COVID-19 and arrhythmia: The factors associated and the role of myocardial electrical impulse propagation. An observational study based on cardiac telemetric monitoring 172
Chronic HCV infection and neurological and psychiatric disorders: an overview. 171
HBV Infection and Host Interactions: The Role in Viral Persistence and Oncogenesis 170
Predictors of early and late hepatocellular carcinoma recurrence 170
Cannabinoid receptor 2 (CB2) Q63 variant is associated with a severe histological activity index in patients with chronic hepatitis C 169
Epstein Barr virus infection reactivation as a possible trigger of primary biliary cirrhosis-like syndrome in a patient with multiple sclerosis in the course of fingolimod treatment. 168
Sonoporation by microbubbles as gene therapy approach against liver cancer 168
Circulating MiRNA-195-5p and -451a in Diabetic Patients with Transient and Acute Ischemic Stroke in the Emergency Department 168
Crioglobulinemia mista essenziale associata a cirrosi epatica: aspetti clinici e terapeutici.Esperienza su una casistica clinica 167
Eighteen-month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy 167
Ittero in corso di infezione delle vie urinarie. Presentazione di un caso clinico ed aspetti patogenetici 166
Adherence to Barcelona Clinic Liver Cancer guidelines in field practice: Results of Progetto Epatocarcinoma Campania 166
Mortality and risk factors of vaccinated and unvaccinated COVID-19 frail patients treated with anti-SARS-CoV-2 monoclonal antibodies. A real-world study 164
An in-vitro study of treatment of drug-induced cholestasis by tauroursodeoxycholate (TUDC). 164
All-oral interferon-free treatments: The end of hepatitis C virus story, the dream and the reality 163
Aspirin in a Diabetic Retinopathy Setting: insights from NO BLIND Study 163
Factors affecting long-term changes of liver stiffness in direct-acting anti-hepatitis C virus therapy: a multicenter prospective study 163
Circulating miRNA-195-5p and -451a in Patients with Acute Hemorrhagic Stroke in Emergency Department 162
Tenofovir disoproxil fumarate monotherapy maintains HBV suppression achieved by a "de novo" combination of lamivudine-adefovir: a pilot study 162
The impact of the CB2-63 polymorphism on the histological presentation of chronic hepatitis B. 161
Boceprevir or telaprevir in hepatitis C virus chronic infection: The Italian real life experience. 161
Efficacy and safety of the sofosbuvir/velpatasvir combination for the treatment of patients with early mild to moderate COVID-19 160
Ruolo eziologico e patogenetico del virus dell'epatite C (HCV) nella crioglobulinemia mista (CM) in pazienti con epatite cronica (EC). 159
Chronic HCV Infection is risk of atherosclerosis. Role of HCV and HCV-related steatosis 159
Atherosclerosis and chronic hepatitis C virus (HCV) infection: Role of liver steatosis 159
Remdesivir plus dexamethasone versus dexamethasone alone for the treatment of COVID-19 patients requiring supplemental O2 therapy: a prospective controlled non-randomized study 159
Aspetti clinico terapeutici della crioglobulinemia mista associata all’epatite cronica C: esperienza su un ampia casistica. 158
[Enterococcal endocarditis: clinical and microbiological features of our series] 157
. Cinetica precoce dell’HCV-RNA in pazienti con epatite cronica: correlati clinico-virologici e valore predittivo la risposta al trattamento antivirale 157
Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview. 156
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 154
Long-Term Prognosis among COVID-19 Patients: The Predictive Role Played by Hyperinflammation and Arrhythmic Disorders in Fatal Outcome 154
[Effect of levamisole on changes in the of hepatic RES induced by chronic ethanol poisoning] 152
Antimicrobials and biological activities of immune system 151
Virological patterns of HCV patients with failure to interferon-free regimens. 150
Chronic Hepatitis C Virus Infection and Depression. 150
Antibiotici 149
Endotoxin protects against chlorpromazine-induced cholestasis in the isolated perfused rat liver 148
Editorial – Role of Highly Active Antiretroviral Therapy (HAART) for the COVID-19 treatment 148
Clinical application of lung ultrasound score on COVID-19 setting: a regional experience in Southern Italy 148
Antimicrobials and biological activities of immune system. Relazione al " Bologna,pag. 3-10. 146
L'endocardite da Enterococco: nostra esperienza nel periodo 1988-93. 146
Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccination 145
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy 145
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 144
Alcohol Consumption and Liver Metabolism in the Era of MASLD: Integrating Nutritional and Pathophysiological Insights 143
Prevalence of antibiotic resistance among clinical isolates of methicillin-resistant staphylococci 143
PNPLA3 l148M variant as a risk factor for carotid atherosclerosis in chronic epatiti C 143
Infective endocarditis due to high-level gentamicin and glycopeptides resistant enterococci: efficacy of the ampicillin-fluoroquinolones combination 142
Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection 141
Ruolo patogenetico dell'adiponectina nella steatosi associata ad epatite C 141
Hepatic steatosis and necro-inflammatory activity overestimated liver stiffness by transient elastography in staging liver fibrosis in chronic hepatitis C 141
Severe Hyponatremia in the elderly: the seasonalvariability in the emergency department 141
Sodium-Glucose Co-Transporters Family: Current Evidence, Clinical Applications and Perspectives 140
Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients 140
Treatment of chronic hepatitis B in children with prednisone followed by alpha-interferon: a controlled randomized study 139
antibiotici 139
Metabolic and renal changes in patients with chronic hepatitis C infection after hepatitis C virus clearance by direct‐acting antivirals 139
Effect of prednisone priming followed by alpha-interferon in treatment of children with chronic hepatitis B: an interim analysis of a controlled trial 138
EFFICACIA DEL TRATTAMENTO CON INTERFERONE RICOMBINANTE E LINFOBLASTOIDE IN PAZIENTI CON EPATITE CRONICA DA HCV 138
No effect of MTP polymorphisms on PNPLA3 in HCV-correlated steatosis 138
Changes in clinical scenarios, management, and perspectives of patients with chronic hepatitis C after viral clearance by direct-acting antivirals 138
Liver Involvement during SARS-CoV-2 Infection Is Associated with a Worse Respiratory Outcome in COVID-19 Patients 137
Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C patients. 137
Treatment of pulmonary nocardiosis in heart-transplant patients: importance of susceptibility studies 137
Comparison of dual HBV-HCV versus single HBV or HCV infections in a previous oncologic pediatric population. 137
Effect of endotoxin tolerance on drug hepatotoxicity: amelioration of taurolithocholate cholestasis in the perfused rat liver 136
La epatite cronica da HCV con steatosi si associa ad elevato rischio aterosclerotico. 136
Celiachia silente in pazienti con epatite C: prevalenza, effetto del trattamento con alfa-interferone sull’attivazione della malattia ed evoluzione clinica 136
Liver's functional alterations produced from erythromycin estolate in the isolated and perfused rat liver 135
Esperienza con l'interferone linfoblastoide nelle epatiti croniche virali 135
Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations. 135
Totale 16.294
Categoria #
all - tutte 182.426
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 182.426


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.387 0 0 0 60 879 22 29 67 110 220 212 788
2022/20235.182 462 88 63 392 679 405 17 334 2.492 43 103 104
2023/20241.971 149 69 76 174 718 241 23 63 8 22 131 297
2024/20256.167 26 76 86 130 989 944 801 498 787 1.031 466 333
2025/202624.112 758 862 1.128 1.231 1.956 13.998 1.397 749 983 507 369 174
2026/20274.134 149 613 1.680 1.692 0 0 0 0 0 0 0 0
Totale 52.378